Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients.
Sokolenko AP, Moiseyenko FV, Iyevleva AG, Ivantsov AO, Dolmatov GD, Shelekhova KV, Gulo EV, Topal AX, Artemieva EV, Abduloeva NH, Rysev NA, Barsova DA, Levchenko NV, Volkov NM, Egorenkov VV, Moiseyenko VM, Imyanitov EN. Sokolenko AP, et al. Among authors: imyanitov en. Int J Mol Sci. 2023 Jan 18;24(3):1870. doi: 10.3390/ijms24031870. Int J Mol Sci. 2023. PMID: 36768191 Free PMC article.
NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
Buslov KG, Iyevleva AG, Chekmariova EV, Suspitsin EN, Togo AV, Kuligina ESh, Sokolenko AP, Matsko DE, Turkevich EA, Lazareva YR, Chagunava OL, Bit-Sava EM, Semiglazov VF, Devilee P, Cornelisse C, Hanson KP, Imyanitov EN. Buslov KG, et al. Among authors: imyanitov en. Int J Cancer. 2005 Apr 20;114(4):585-9. doi: 10.1002/ijc.20765. Int J Cancer. 2005. PMID: 15578693 Free article.
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.
Sokolenko AP, Mitiushkina NV, Buslov KG, Bit-Sava EM, Iyevleva AG, Chekmariova EV, Kuligina ESh, Ulibina YM, Rozanov ME, Suspitsin EN, Matsko DE, Chagunava OL, Trofimov DY, Devilee P, Cornelisse C, Togo AV, Semiglazov VF, Imyanitov EN. Sokolenko AP, et al. Among authors: imyanitov en. Eur J Cancer. 2006 Jul;42(10):1380-4. doi: 10.1016/j.ejca.2006.01.050. Epub 2006 Jun 5. Eur J Cancer. 2006. PMID: 16737811
CHEK2 1100delC mutation is frequent among Russian breast cancer patients.
Chekmariova EV, Sokolenko AP, Buslov KG, Iyevleva AG, Ulibina YM, Rozanov ME, Mitiushkina NV, Togo AV, Matsko DE, Voskresenskiy DA, Chagunava OL, Devilee P, Cornelisse C, Semiglazov VF, Imyanitov EN. Chekmariova EV, et al. Among authors: imyanitov en. Breast Cancer Res Treat. 2006 Nov;100(1):99-102. doi: 10.1007/s10549-006-9227-7. Epub 2006 Jun 7. Breast Cancer Res Treat. 2006. PMID: 16758118
Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia.
Sokolenko AP, Rozanov ME, Mitiushkina NV, Sherina NY, Iyevleva AG, Chekmariova EV, Buslov KG, Shilov ES, Togo AV, Bit-Sava EM, Voskresenskiy DA, Chagunava OL, Devilee P, Cornelisse C, Semiglazov VF, Imyanitov EN. Sokolenko AP, et al. Among authors: imyanitov en. Fam Cancer. 2007;6(3):281-6. doi: 10.1007/s10689-007-9120-5. Epub 2007 Feb 28. Fam Cancer. 2007. PMID: 17333477
Cell technologies in immunotherapy of cancer.
Moiseyenko V, Imyanitov E, Danilova A, Danilov A, Baldueva I. Moiseyenko V, et al. Adv Exp Med Biol. 2007;601:387-93. doi: 10.1007/978-0-387-72005-0_42. Adv Exp Med Biol. 2007. PMID: 17713028 Review.
268 results